|Publication number||USD613400 S1|
|Application number||US 29/348,228|
|Publication date||Apr 6, 2010|
|Priority date||Mar 15, 2007|
|Also published as||CA121828S, CA125153S, CA125154S, CA125155S, CA125156S, USD612487, USD613399, USD613401, USD613861|
|Publication number||29348228, 348228, US D613400 S1, US D613400S1, US-S1-D613400, USD613400 S1, USD613400S1|
|Inventors||Mark W. Hunter, Heath A. Doty, Bryce G. Rutter, Melvin J. Leedle|
|Original Assignee||Bristol-Myers Squibb Company|
|Export Citation||BiBTeX, EndNote, RefMan|
|Non-Patent Citations (1), Referenced by (4), Classifications (1) |
|External Links: USPTO, USPTO Assignment, Espacenet|
Overcap for injector
US D613400 S1
The ornamental design for an overcap for injector, as shown and described.
FIG. 1 is a perspective view of an overcap for injector showing the design.
FIG. 2 is an end view of the design of FIG. 1, showing the top end visible in FIG. 1.
FIG. 3 is a side elevation view showing the design of FIG. 1; and,
FIG. 4 is a side elevation view in a direction rotated 90 degrees from the view of FIG. 3 showing the design of FIG. 1.
Nature and intended use of the article in which the design is embodied: A protective overcap for an injector for administrating an injection into a human or animal subject; the overcap is removed prior to administration of the injection.
|1||Abbott Laboratories, Humira Pen Injector Product Description (circa 2006).|
|Citing Patent||Filing date||Publication date||Applicant||Title|
|US9216256||Oct 15, 2010||Dec 22, 2015||Janssen Biotech, Inc.||Palm activated drug delivery device|
|US9233213||Mar 15, 2013||Jan 12, 2016||Janssen Biotech, Inc.||Palm activated drug delivery device|
|US20110092915 *||Apr 21, 2011||Centocor||Palm activated drug delivery device|
|USD731650 *||Jun 13, 2012||Jun 9, 2015||Sterilance Medical (Suzhou) Inc.||Pulltop lancet|